Mar 6
|
Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
|
Mar 5
|
Viridian Therapeutics to Participate in the Leerink Partners Global Biopharma Conference
|
Sep 25
|
Insider Traders Lose US$114k As Viridian Therapeutics Drops
|
Sep 25
|
Viridian Appoints Sarah Gheuens, M.D., Ph.D., to its Board of Directors
|
Sep 7
|
Viridian Therapeutics Announces Presentations at Multiple Medical Meetings in September
|